Respiratory syncytial virus (RSV) is a well-known cause of infections in children, but it's understudied in older individuals ...

In older adults, respiratory syncytial virus (RSV) is associated with an increased risk for cardiovascular outcome, especially heart failure events.

That compared to 59.5% for RSV-A and 57.5% for RSV-B at the visit before the second RSV season. This was much higher than the placebo, which included 3% who had immune responses to RSV-A and 7.7% ...

In older adults, GSK's shot showed a cumulative efficacy of 67.2% against lower respiratory tract illness over two RSV seasons. That's compared with 82.6% after one season of the virus.

Respiratory syncytial virus (RSV) is a well-known cause of infections in children, but it's understudied in older individuals ...

Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...

A single dose of RSVPreF3 OA offered protection against RSV-related lower respiratory tract disease across three RSV seasons ...

The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...

Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

Respiratory syncytial virus (RSV) infections in older adults lead to significantly more severe health outcomes and long-term cardiovascular complications compared to other common causes of ...

COVID, Flu and RSV: Why Older Adults Need to Get Vaccinated U.S. News & World Report February 19, 2025, 7:00 PM ...

The risk for those outcomes, as well as for heart attack, “was at least two to three times higher in patients with a ...